RedHill Biopharma | RDHL - Current Liabilities


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

RedHill Biopharma

RedHill Biopharma reported $197.45M in Current Liabilities for its fiscal quarter ending in December of 2022.


Current Liabilities Change
Adamis Pharmaceuticals ADMP:US USD 12.95M 1.55M
Cara Therapeutics CARA:US USD 16.68M 6.78M
Cronos Group Inc CRON:CN USD 29.13M 38.98M
Intra Cellular Therapies ITCI:US USD 79.59M 3.65M
RedHill Biopharma RDHL:US USD 197.45M 3.92M